share_log

Returns Are Gaining Momentum At IVD Medical Holding (HKG:1931)

Returns Are Gaining Momentum At IVD Medical Holding (HKG:1931)

华检医疗控股公司的收益正在增长势头(HKG:1931)
Simply Wall St ·  2024/12/14 06:34

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. So when we looked at IVD Medical Holding (HKG:1931) and its trend of ROCE, we really liked what we saw.

如果我们想识别长期内能够增值的股票,应该关注哪些趋势呢?理想情况下,一个业务会展现出两个趋势;首先是资本回报率(ROCE)的增长,其次是使用的资本量的增加。这显示出它是一个复合增长机器,能够不断将收益再投资于业务中并产生更高的回报。当我们查看华检医疗控股(HKG:1931)及其ROCE趋势时,我们非常喜欢我们看到的。

Return On Capital Employed (ROCE): What Is It?

资本回报率(ROCE):它是什么?

If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on IVD Medical Holding is:

如果您之前没有使用过ROCE,它衡量的是公司从其业务中使用的资本所产生的“回报”(税前利润)。华检医疗控股的此计算公式为:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

资本利用率 = 利息和税前利润(EBIT) ÷ (总资产 - 流动负债)

0.11 = CN¥395m ÷ (CN¥5.3b - CN¥1.7b) (Based on the trailing twelve months to June 2024).

0.11 = CN¥39500万 ÷ (CN¥53亿 - CN¥1.7亿)(基于截至2024年6月的过去十二个月)。

So, IVD Medical Holding has an ROCE of 11%. On its own, that's a standard return, however it's much better than the 8.5% generated by the Healthcare industry.

因此,华检医疗控股的ROCE为11%。单看这一点,这是一个标准回报,然而,远比医疗行业的8.5%要好得多。

big
SEHK:1931 Return on Capital Employed December 13th 2024
SEHK:1931 资本回报率 2024年12月13日

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you're interested in investigating IVD Medical Holding's past further, check out this free graph covering IVD Medical Holding's past earnings, revenue and cash flow.

虽然过去的表现不能代表未来,但了解一家公司的历史表现是有帮助的,这就是我们上面有这张图表的原因。如果你有兴趣进一步调查华检医疗的历史,可以查看这张免费的图表,涵盖华检医疗的过去收益、营业收入和现金流。

What Does the ROCE Trend For IVD Medical Holding Tell Us?

华检医疗的ROCE趋势告诉我们什么?

The trends we've noticed at IVD Medical Holding are quite reassuring. Over the last five years, returns on capital employed have risen substantially to 11%. The amount of capital employed has increased too, by 63%. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.

我们在华检医疗注意到的趋势相当令人安心。在过去五年中,资本回报率显著上升至11%。使用的资本量也增加了63%。这表明内部投资资本的机会很多,并且投资回报率不断提高,这是多倍收益股常见的组合。

Our Take On IVD Medical Holding's ROCE

我们对华检医疗ROCE的看法

In summary, it's great to see that IVD Medical Holding can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. Given the stock has declined 41% in the last five years, this could be a good investment if the valuation and other metrics are also appealing. So researching this company further and determining whether or not these trends will continue seems justified.

总的来说,看到华检医疗通过持续将资本再投资于不断提高的收益率来复合收益是很棒的,因为这些是那些备受追捧的多倍收益股的一些关键成分。考虑到该股票在过去五年中下跌了41%,如果估值和其他指标也令人满意,这可能是一个不错的投资。因此,进一步研究这家公司并确定这些趋势是否会继续似乎是合理的。

On a final note, we've found 2 warning signs for IVD Medical Holding that we think you should be aware of.

最后,我们发现华检医疗有2个警告信号,我们认为你应该注意。

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

对于喜欢投资于稳健公司的投资者,可以查看这个免费的稳健资产负债表和高股本回报率公司的列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发